Business Wire

Saudi Delegation Highlights Kingdom’s Evolving Global Growth Story at World Economic Forum

Share

Saudi Arabia’s smart city NEOM offers a new model for environmentally-friendly and sustainable urban design, both for the Kingdom and the world, Saudi’s Climate Envoy told the World Economic Forum (WEF) today.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230120005356/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Saudi’s Climate Envoy speaks at the World Economic Forum about creating sustainable future cities (Photo: AETOSWire)

During a panel session titled ‘The Evolution of Urban Life’, His Excellency Adel bin Ahmed Al-Jubeir, Minister of State for Foreign Affairs and Climate Envoy for Saudi Arabia, said: “[The Line] will revolutionize the way people look at cities and urban planning. NEOM is an attempt to create a city that is environmentally friendly, sustainable, that has a very high quality of life, that has virtually no traffic.”

His Excellency Khalid bin Abdulaziz Al-Falih, Minister of Investment, participated in a session called ‘Reshuffling Value Chains’. He described how Saudi Arabia’s supply chain initiatives will leverage the Kingdom’s resources, infrastructure, and location to enhance local and global supply chain resilience.

“In Saudi Arabia, we launched the Global Supply Chain Resilience Initiative (GCSRI), to not only strengthen our resilience but also enable the Kingdom to become part of the global multi-hub system, while playing to our strengths.”

During a session titled Deployment in the Industrial Metaverse, His Excellency Abdullah bin Amer Alswaha, Minister of Communications & Information Technology, said: “The current 2D world that we live in today is not fit for purpose in the 21st century.

“I'm a big advocate of the metaverse, which is going to be the next wave of how immersive experiences work for consumers, enterprises, and industry. We are bringing together academics, innovators, policymakers and regulators into a sandbox to make sure that they have a safe environment to innovate.”

His Excellency Faisal F. Alibrahim, Saudi Arabia’s Minister of Economy and Planning told the WEF audience the Kingdom is set to surpass projected growth rates for 2023.

“Saudi is becoming the global growth story. We had the strongest growth in the G20 last year and if you look more closely at the 8.5 percent GDP growth figure, you will see that our non-oil activities and our private sector grew at a very high rate,” he said.

Earlier, Alibrahim addressed a panel on global tax reform, where he said: “Under Saudi Vision 2030, we have been focusing on detaching ourselves from traditional sources of revenue, with our economic diversification, to think about more long-term sustainable revenue generation, but also diversifying our sources of growth.”

In addition to the panel sessions, the Ministry of Economy and Planning for Saudi Arabia joined forces with WEF’s open innovation platform UpLink to launch a challenge designed to enhance food security in countries with arid climates. The Food Ecosystems and Arid Climates Challenge is a global call for technology solutions to food insecurity.

*Source: AETOSWire

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Wooud Alquaied
walquaied@mep.gov.sa

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

ReNAgade Therapeutics Continues Commitment to GanNA Bio and Glycan Biology27.4.2024 03:09:00 EEST | Press release

ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the integration of key individuals of GanNA Bio into the ReNAgade ecosystem. GanNA founders Carolyn Bertozzi, Ph.D., and Richard D. Cummings, Ph.D, will now serve as advisors to ReNAgade. “ReNAgade will continue to benefit tremendously from GanNA’s promising work in developing extra-hepatic delivery technology that helps expand the breadth and potential of our own RNA medicines,” said Brian Goodman, Co-founder of ReNAgade. “Delivery is foundational to ReNAgade’s mission to overcome the current limitations of RNA medicines. We believe the technology developed within GanNA will help further solidify ReNAgade’s leadership position as we continue advancing our unique, integrated therapeutic platform.” Formed in 2021 and invested in by ReNAgade, GanNA Bio ha

HCLTech Reports FY24 Revenue of $13.3 Billion, up 5.4% YoY26.4.2024 23:06:00 EEST | Press release

HCLTech, a leading global technology company, today reported financial results for the fourth quarter and the full year ended March 31, 2024. The company reported full year revenue of $13.3 billion, up 5.4% YoY. Digital Services revenue grew by 5.3% (CC) and now contributes to 37.3% of IT Services revenue. HCLSoftware’s Annual Recurring Revenue came in at $1.02 billion. During FY24, the company won 73 large deals – 36 in Services and 37 in Software - that translated into TCV (new deal wins) of $9.76 billion, up 10% YoY. For the quarter, revenue came in at $3.43 billion, up 6% YoY. HCLTech won 21 large deals – 13 in Services and eight in Software, with a TCV of $2.29 billion during the quarter. In terms of geographies, Americas was the fastest growing region with 6.8% YoY (CC) growth followed by Europe, which grew by 5.5% YoY (CC). Industry vertical growth was led by Financial Services and Telecommunications, Media, Publishing & Entertainment. While Financial Services grew at 12.1% YoY

Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 19:03:00 EEST | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio

Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 18:43:00 EEST | Press release

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)

Suzano 2023 annual report on Form 20-F26.4.2024 18:22:00 EEST | Press release

Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/ Contact information Hawthorn Advisors suzano@hawthornadvisors.com

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye